 ROCKVILLE, Md., Sept. 7, 2021 PRNewswire -- Renowned gene therapy pioneer and biotechnology executive bring extensive RD leadership and financial and operational expertise to the Board REGENXBIO Inc. Nasdaq: RGNX today announced the appointment of Jean Bennett, M.D. 